Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Xarelto Approved, But No Fireworks Yet
Motley Fool
Tuesday, July 5, 2011 - 4:42pm
tags:
blood thinners, Xarelto, Bayer, JNJ
pSivida on the Cusp of Big Breakthrough
Seeking Alpha
Tuesday, July 5, 2011 - 4:39pm
tags:
Pfizer, pSivida, diabetic macular edema, injectables, age-related macular degeneration, Durasert, glaucoma
Eli Lilly Reaffirms Commitment to Innovation but Needs to Deliver
Seeking Alpha
Tuesday, July 5, 2011 - 4:37pm
tags:
innovation, Eli Lilly, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
Painkillers linked to atrial fibrillation in Danish study
Pharma Times, UK
Tuesday, July 5, 2011 - 11:52am
tags:
painkillers, atrial fibrillation, NSAIDs, COX-2 inhibitors
E-Prescribing & Handwritten Error Rates Are Similar
Pharmalot
Tuesday, July 5, 2011 - 11:51am
tags:
e-prescribing, physicians
Harvard docs punished for undisclosed pharma ties
Fierce Pharma
Tuesday, July 5, 2011 - 11:33am
tags:
Harvard, physician payments, physicians
Jazz Reaches New 52-Week High
TheStreet.com
Tuesday, July 5, 2011 - 11:32am
tags:
Jazz Pharmaceuticals
Adventrx's Exelbine Could Be Available This Year
Seeking Alpha
Tuesday, July 5, 2011 - 11:30am
tags:
Exelbine, Adventrx, Small-Cell Lung Cancer
Seattle Genetics, on the Verge of Going Commercial, Seeks to Keep Its Scientific Soul
Motley Fool
Tuesday, July 5, 2011 - 11:29am
tags:
Seattle Genetics
Eight years in the making, N.J.-based Merck developing new kind of insomnia drug
Newark Star-Ledger, NJ
Tuesday, July 5, 2011 - 11:28am
tags:
Merck, insomnia
Merck commits to increased transparency on study protocols
Pharma Times, UK
Tuesday, July 5, 2011 - 11:21am
tags:
Merck, transparency, clinical trials
A Link Between Antidepressants And Autism?
Pharmalot
Tuesday, July 5, 2011 - 11:20am
tags:
autism, SSRIs, antidepressants, pregnancy
Pfizer Stock Rises Despite Concerns About Stop-Smoking Drug
Barron's
Tuesday, July 5, 2011 - 10:57am
tags:
Pfizer, Chantix, smoking cessation
Par Restructures Branded Business
Yahoo/Zacks.com
Tuesday, July 5, 2011 - 10:56am
tags:
Par Pharmaceutical, reorganization, AstraZeneca
GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
Yahoo
Tuesday, July 5, 2011 - 10:54am
tags:
GSK, drug reps, compensation
Novartis to File Drug for Breast Cancer
WSJ Online
Tuesday, July 5, 2011 - 10:05am
tags:
Novartis, breast cancer, Afinitor
July Catalysts for Biotech and Drug Stocks
Minyanville
Tuesday, July 5, 2011 - 9:58am
tags:
Seattle Genetics, Bristol-Myers Squibb, JNJ, advisory panels, FDA, Transcept, AstraZeneca, GSK, Human Genome Sciences, Merck, Theravance, Amgen, Biogen Idec, Acorda Therapeutics
Titan Pharmaceuticals Is Back in Play With FDA Questions Resolved
Seeking Alpha
Tuesday, July 5, 2011 - 9:55am
tags:
FDA, Titan, Novartis, Vanda, Probuphine
Generics advancing on lucrative pet drug market
Yahoo/AP
Tuesday, July 5, 2011 - 9:54am
tags:
generics, animal health
Pfizer's Chantix Weighed by FDA After 72% Added Heart Risk
Bloomberg
Tuesday, July 5, 2011 - 9:53am
tags:
smoking cessation, Pfizer, Chantix, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.